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Summary 
Humoral immune responses are initiated by binding of antigen to the immunoglobulins (Igs) 
on the plasma membrane of B lymphocytes. On the cell surface, Ig forms a complex with several 
other proteins,  two of which, MB-1 and B29, have been implicated in ~eceptor assembly. We 
have reconstituted Ig receptor function in T  lymphocytes by transfection  of cloned receptor 
components. We found that efficient  transport of IgM to the surface  of T cells required coexpression 
of B29. Furthermore, IgM and B29 alone were sufficient to reconstitute antigen-specific signal 
transduction by Ig in the transfected  T cells. Crosslinking of IgM with either antireceptor antibodies 
or antigen induced a calcium flux, phosphoinositol  turnover, and interleukin secretion in T cells. 
These experiments  establish a requirement for B29 in Ig receptor function, and suggest  that 
the signaling  apparatus of T  and B cells is structurally homologous. 
T 
he antigen receptors of  B and T lymphocytes are members 
of the Ig supergene family whose specificity is deter- 
mined by a series of genomic rearrangements.  In both cases, 
the ligand binding domains of the receptors are defined by 
the combination of two independently encoded polypeptides 
that are linked by disulfide bonds. In addition, both receptors 
are associated with a number of other proteins  on the cell 
surface. The TCR is a complex of at least six different poly- 
peptides, including the antigen-specific c~/~ or "y/8 chains, 
associated with the CD3 e, %  8, and ~" or ~/chains,  all of 
which are required for efficient assembly and surface trans- 
port (1-4). The homologues of the TCR-associated proteins 
in B cells are MB1 and B29, also known as IgMc~ and IGMB 
(5-9). MB1 and B29 form a disulfide-linked heterodimer  that 
is associated with IgM (10), and both proteins  share an in- 
tracytoplasmic amino acid sequence motif with CD3 % 8, 
and ~" (11). In addition,  MB1 and B29 appear to be required 
for transport of IgM to the plasma membrane of transfected 
fibroblasts and B cells (10, 12). 
Experiments with mutant T cell lines and isolated TCR 
components have established that the CD3 ~" chain is both 
necessary and sufficient for signal transduction (13-16). In 
addition,  the CD3 e chain is also capable of inducing T cell 
activation,  possibly by an alternative pathway (17). Cross- 
linking of the TCR, or the isolated ~" or e chains, leads to 
CD45-dependent activation of  protein kinases, increased  phos- 
phoinositol turnover, and caldum mobilization. A very similar 
set of events is induced by crosslinking IgM on the surface 
of B cells, but the functional role of the IgM-associated pro- 
teins is poorly defined. 
As an initial step in studying the structural and functional 
requirements for signal transduction by Ig, we have recon- 
stituted the Ig antigen receptor ofB lymphocytes in theJurkat 
T cell line by transfection. We found that transport of IgM 
to the surface ofT cells required coexpression of the Ig heavy 
and light chains  with B29. Furthermore, the transfected 
receptor was fully active in the presence of  B29, and was able 
to couple to the downstream signaling apparatus in T cells. 
MB1, a second IgM-associated polypeptide, was not required 
for either transport or signal transduction. 
Materials and Methods 
Plasmid Construction.  The spleen  focus-forming  virus (SFFV)  1 
LTR from  pFNeo (18) was combined  with the BamHI to EcoRI 
fragment of the human growth hormone to produce an SFFV 
eDNA expression  vector p463. The hGH sequences  and polyade- 
nylation signals  were  added  to increase  mRNA stability  for cDNA 
expression. MB1 and B29 cDNAs obtained  by PCK were  sequenced 
and cloned  into the polylinker  of p463 to obtain the p466-B29 and 
the p467-MB1 expression  vectors. The EcoRJ  fragment  of  the MB1 
expression clone  was then transferred  to the EcoRI site ofpSV2His 
(19) to produce  a plasmid  that carries  both an MB1 expression  vector 
and His resistance,  p474-MB1. The IgM heavy  chain  minigene  was 
composed of the V region of $107 (20) ligated to the HindIII to 
BamHI fragment of a human IgM constant region gene that had 
been modified  to produce  only the membrane-bound  form of IgM 
protein (21). The IgM minigene was cloned  just 3' of the SFFV 
LTR in pFneo cut with SalI and BamHI to make plasmid p459. 
The r minigene was composed  of the $107 light chain V region 
1 Abbreviations used in this paper: IP, inositol phosphate; PC, phosphoryl- 
choline; SFFV, spleen focus-forming virus. 
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chain constant region (23), and the promoter was the EcoRI to 
BamHI fragment of the SFFV LTR. The heavy  and light chains 
were combined in a single plasmid by cloning the light chain 
minigene into the unique BamHI site of p459 to produce I>468, 
a plasmid that carries the PC-specific  heavy  and light chains, and 
neomycin resistance genes. 
CelILines.  Jurkat cells  were grown in RPM11640 supplemented 
with 10% bovine calf serum, 50 U/ml penicillin, 50 ~g/ml strep- 
tomycin, and 2 mM t-glutamine (R10). Cells were transfected  with 
linear plasmid DNA by electroporation (24), and selection  was car- 
tied out in R10 with 0.7 mg/ml ofG418 (Gibco  Laboratories,  Grand 
Island, NY), and/or 5 mM L-histidinol  (Sigma Chemical Co., St. 
Louis, MO).  Resistant cell lines were stained with  10 /~g/ml 
fluorescein-hbeled goat anti-human IgM (Southern Biotechnology 
Assodates, Birmingham, AL) and positive  cells sorted on a FACStar 
Plus  |  (Becton Dickinson & Co., Mountain View, CA). Analysis 
of surface staining was performed with the same antibody using 
a FACScan  |  (Becton Dickinson & Co.). 
Antibodies.  Monodonal anti-human IgM,  DA4.4 (25), and 
anti-human CD-3, OKT 3 (26), were purified from either ascites 
or tissue culture media by precipitation with ammonium sulfate 
and chromatography on protein A-Sepharose, Goat anti-human 
IgM, either labeled  with fluorescein  or unhbded, IgG1 monoclonal 
isotype control antibody, and goat anti-mouse IgG, were from 
Southern Biotechnology Associates. 
Northern Analysis.  RNA was prepared as described (27). After 
electrophoresis and transfer, blots were hybridized  with either B29 
cDNA or MB1 antisense RNA as described (28). 
Iodinations, Affinity Purification, and Protein Electrophoresis.  3-6 
￿  107 viable cells were labeled with 3-4 mCi of NaUSI and lac- 
toperoxidase/glucose  oxidase as described (29), and solubilized in 
1% digitonin, 100 mM NaC1, 50 mM Tris-HC1 (pH 6.8), 1 mM 
PMSF at 4~  for 30 min. Insoluble material was separated  by cen- 
trifugation and the supernatant fraction was incubated with phos- 
phorylcholine (PC) beads for 4-5 h. The beads were washed three 
times with 0.1% digitonin, 100 mM NaCI, 50 mM Tris-HC1 (pH 
6.8) for 5 min. Elution of IgM was carried out by incubating the 
beads for 1 h with wash buffer supplemented with 20 mM PC. 
Protein samples were analyzed by SDS-PAGE on 7% gels under 
reducing conditions. The protein bands were visualized by silver 
staining. A Phosphor Imager (Molecular Dynamics) was used to 
visualize lzSI-labeled proteins. 
Calcium Flux Measurements.  Cells  were resuspended at 5  x 
lO~/ml in PBS supplemented  with 5.6 mM glucose, 0.025% BSA, 
20 mM Hepes (pH 7.0), 1 mM CaClz, 1 mM MgCla (loading 
buffer), and 3/zg/ml Fura-2AM (Sigma Chemical Co.), and in- 
cubated at 37~  for 30 min followed  by three washes with loading 
buffer. The Fura-2-1oaded cells were then resuspended in loading 
buffer at a concentration of 106/ml, and fluorescence  was measured 
in a spectrofluorimeter  (SPF-500C; SLM Aminco Instruments Inc., 
Urbana, IL), where the excitation wavelength was 335 nm and 
emission was recorded at 510 nm. Calcium concentration was cal- 
culated as described (30). 
PC-BSA and PC-Sepharose.  BSA dissolved  in PBS was incubated 
overnight with para-diazoniumphenylphosphorylcholine  (DPPC) 
synthesized according to reference 01). Modified BSA (PC-BSA) 
was separated from unreacted DPPC by cohmn chromatography 
on Sephadex  G25 in PBS. For the synthesis of  PC beads, the dipep- 
tide alanyltyrosine  was coupled to CNBr-activated  Sepharose (Phar- 
macia Fine Chemicals, Piscataway, NJ). The beads were washed 
in PBS, and freshly synthesized DPPC was added, incubated over- 
night, washed with water, and stored at 4~ 
11.,2 Bioassay.  Cells  to be tested for IL-2 production were sus- 
pended at 1.2  x  106/ml in tissue culture media and used directly 
or pretreated with either, 10/~g/ml anti-CD3, 20/~g/ml of  DA4.4 
monoclonal anti-human IgM, or 10/~g/ml of an IgG1 monoclonal 
isotype control antibody for 30 rain at 4~  Unbound antibody 
was removed by extensive  washing with PBS. 2  x  104 cells were 
then phted in the wells of a 96-well tissue culture plate precoated 
with either 10/~g/ml  goat anti-mouse IgG (Southern  Biotechnology 
Associates), 10/zg/ml PC-BSA, 10/zg/ml BSA, or nothing. PMA 
was added at a final concentration of 10 ng/ml. Supematants were 
harvested after 24 h and bioassays  were performed using the CTLL- 
2.20 ID2-dependent cell line as described (32). 
Inositol Phosphate Assay.  Cells were incubated for 4 h with 
[3H]myo-inositol  at 15/zCi/ml, and 3-4  x  106 cells/ml in inositol- 
free RPMI 1640 supplemented  with 10% dialyzed  bovine  calf  sertun. 
Excess [3H]-myo-inositol  was removed by washing in PBS. The 
loaded cells were then resuspended at  2  x  106/ml in  Hepes- 
buffered saline supplemented with 10 mM LiC1, and equilibrated 
for 15 rain at 37~  The cells were sequentially stimulated with 
1/~g/ml of  either anti-CD3, DA4.4 monoclonal anti-human IgM, 
or the IgG1 isotype control followed after 10 s by 10/~g/ml  of 
goat anti-mouse IgG crosslinking  reagent. The incubation was ter- 
minated after 3 min by adding of 8 ml of 2:1 methanol/chloroform 
and the extracted material was subjected to chromatography on 
1-ml columns of  Dowex AG-1-8 (Bio-Rad  Laboratories,  Richmond, 
CA). Inositol phosphates were eluted with 0.1 M formic acid con- 
taining increasing concentrations of ammonium formate (0.2 M 
for inositol phosphate [IP], 0.4 M for IP2, 0.8 M for IP3, and 1 M 
for IP4). The eluted radioactivity was quantitated by liquid scintil- 
lation counting. 
Results 
Surface Extnr.uion of lgM in T Cellx  PC-specific Ig receptor 
components were expressed in T cells by stable transfection 
of DNA constructs based on an SFFV-LTR promoter (18) 
(Fig. 1 A). A human IgM heavy chain minigene that directs 
the synthesis of membrane-anchored IgM (21) was combined 
with a PC-spedfic heavy chain variable region (20). The light 
chain was composed of the corresponding r  variable region 
(22),  coupled to a human r  constant region gene (23).  To 
insure coordinate expression of the Ig heavy and light chains, 
the two transcription units were combined in a single plasmid 
with a neomycin resistance gene. Human growth hormone 
polyadenylation and splice consensus sequences (18) were added 
to mouse MB1 and B29 cDNAs, and a histidinol resistance 
gene was included as a second drug resistance marker in the 
MB1 expression  vector (19). 
IgM expression was readily detected on the surface of  Jurkat 
cells transfected with IgM and B29, or a combination of IgM, 
MB1,  and B29.  In  contrast,  surface  IgM expression was 
difficult to detect on Jurkat cells transfected with either the 
heavy and light chain alone,  or a combination of IgM and 
MB1. In all cases we enriched for surface IgM-positive cells 
by selection with a FACS  ~  (Fig. 1 B). High levels of surface 
IgM expression  were achieved after one or two rounds of 
selection  of cell lines transfected with either IgM and B29, 
or IgM, B29,  and MB1.  However, eight rounds of sorting 
were required for cell lines transfected with IgM alone, while 
the combination of IgM and MB1 was always negative (Fig. 
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Figure 1.  DNA constructs, and cell surface  expression  of human Ig in 
transfected  Jurkat cells. (A) Maps oflg, B29, and MB1 expression  vectors. 
The SFFV-LTK  promoter was used in all constructs for T cell expression. 
Human growth hormone introns and polyadenylation  signals were added 
to both B29 and MB1 cDNAs, and a histidinol resistance gene was in- 
cluded in the MB1 plasmid. A PC-specific  mouse variable region from 
$107 was combined with a human heavy  chain constant region engineered 
to direct the synthesis of only the membrane bound form of IgM. The 
light chain was composed of an $107 g variable region and the lmman 
r constant  region. The heavy  chain  and light chain  were  on the same  plasmid 
as a neomycin  resistance gene. (B) Flow cytometric analysis of surface ex- 
pression of human IgM on transfected  Jurkat cells. Relative cell number 
is plotted against fluorescence  intensity on a logarithmic scale. The con- 
strncts transfected, cell line, and the number of times the cell line was 
sorted to enrich for surface  expression (SX,) are indicated at the top of 
each panel. Control  indicates unstained cells, and GAHIGM indicates 
staining with FITC-conjugated goat anti-human IgM. B29, B29 cDNA; 
MB1, MB1 cDNA; hGH, human growth hormone splice  and polyadenyl- 
ation signals; His, histidinol  resistance  gene; mlgM, PC-specific,  membrane- 
bound form of human IgM heavy  chain; kappa, PC-specific  r light chain; 
Neo, neomycin resistance gene; #, cell line number; SXn, the number of 
times a cell line was enriched for surface  IgM by sorting; p467, B29 ex- 
pression vector;  p474, MB1 expression  vector;  p468, IgM expression  vector. 
1 B). We confirmed that the products of the transfected PC- 
specific Ig  genes  were  appropriately  assembled  by  affinity 
purification with PC coupled to Sepharose (PC-Sepharose). 
Equivalent amounts of both heavy and light chains were ob- 
tained  from  extracts  of all cell lines  and  clonal  derivatives 
regardless of the level of surface expression (Fig. 2 A). Thus, 
the level of surface IgM expression (Fig. 2 A). Thus, the level 
of surface IgM expression was not a simple function of the 
amount of IgM synthesis. In addition, the steady-state levels 
of transfected B29 and MB1 mRNA were comparable with 
a B  cell control (Fig.  2 B).  As expected, the mKNAs  pro- 
duced from the transfected genes were somewhat larger than 
their B cell counterparts since they contained additional human 
growth hormone sequences. We concluded that the combi- 
Figure 2.  Expression  oflgM protein, B29, and MB1 mRNAs. (A) Silver- 
stained SDS-polyacrylamide  gel of affinity-purified  PC-binding Ig from 
transfected  Jurkat cells, and controls. (B) Northern analysis of B29 and 
MB1 expression  in the transfected  cell  lines. The cell types,  constructs  trans- 
fected, and cell line number (Fig. 1 B) are indicated at the top of each 
lane: IgM, the starting cell line for production of IgM#3 had 1-2% sur- 
face IgM expression; # and r indicate the position of the heavy and light 
chains determined from purified standards. 
nation of heavy chain,  light  chain,  and B29 was  sufficient 
for efficient transport  of IgM  to the  surface of T  cells.  In 
contrast,  powerful selection was required to obtain  surface 
IgM-positive  cells in  absence of B29. 
Transfected IgM Is Associated with B29 and MBI.  To deter- 
mine whether B29  and  MB1  were associated with  surface 
IgM, transfected T  cell lines were iodinated, and PC-specific 
Ig and associated molecules were purified from digitonin ex- 
tracts by adsorption with PC-Sepharose (Fig. 3). A polypep- 
tide with  the appropriate electrophoretic mobility for B29 
(44 kD) was copurified with Ig heavy and light chains from 
Jurkat cells transfected with IgM and B29. The same poly- 
peptide and three additional species were copurified from the 
IgM, B29, and MB1 transfectants (Fig. 3). The 32-kD band 
Figure 3.  Affinity purification of sur- 
face iodinated proteins from transfected 
cell lines. PC-binding Igs and associated 
polypeptides were at~nity purified from 
1% digitonin extracts  of  surface  iodinated 
cells. The cell types, constructs trans- 
fected, and cell line number are indicated 
at the top of  each lane, the same  as in Fig. 
2 A;/~ and r indicate the position of the 
heavy and light chains determined from 
purified standards. 
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Figure 4.  Calcium flux assays of transfected Jurkat cells. Cells loaded 
with Fura-2 were assayed flnorimetrically for calcium mobilization  in re- 
sponse to either 1.5/~g/ml anti-CD3, 10/~g/ml anti-human IgM, or 10 
/~g/ml isotype control mAb or PC-BSA. The cell types and constructs 
transfected are indicated at left, and reagents added at the top. IgG1, iso- 
type control mAb; a-CD3, anti-CD3 antibody; a-IgM, anti-IgM antibody; 
Jurkat, untransfected Jurkat cells; IgM, Jurkat cells transfected with IgM 
no. 3 (Hg.  1 B); IgM+B29, Jurkat cells transfected with IgM+B29 no. 
4  (Fig.  1  B);  IgM+B29+MB1, Jurkat  cells transfected  with  IgM+ 
B29+MB1  no. 9 (Fig. 1 B); standard scales for time and [Ca  z+ ] are indi- 
cated at the bottom fight. 
was consistent with MB1, the additional bands at 52 and 39 
kD may be alternate forms of B29 and MB1, or T  cell-en- 
coded proteins. As a control, the same experiments were per- 
formed with Jurkat cells that expressed surface IgM alone 
(cell line 3 Fig. 1 B). Although we were able to purify iodi- 
nated Ig heavy and light chains from the IgM control, there 
were no associated proteins (Fig.  3).  Our interpretation of 
these experiments was that B29 was associated with IgM on 
the surface of T  cells, and this interaction occurred in the 
absence of  MB1. Furthermore, when both MB1 and B29 were 
present in the transfected T cells, both were associated with 
IgM. 
Crosslinking of  lgM with Antireceptor  Antibodies Induces Cal- 
cium Mobilization, Phosphoinositd Turnover, and 11,2 Secre- 
tion,  The function of the transfected Ig was initially assessed 
by measurement of calcium flux in response to receptor cross- 
linking.  Fura-2-1oaded  cell  lines  were  treated  with  an 
anti-human IgM mAb, monoclonal anti-CD3, or an isotype- 
matched mAb control. Jurkat cells transfected  with either 
IgM and B29 or IgM, B29, and MB1 responded to cross- 
linking by anti-IgM with a rapid increase in free intracellular 
calcium (Fig. 4). Untransfected  Jurkat cells, and Jurkat cells 
that expressed high levels of IgM alone, did not respond to 
anti-IgM, but were fully competent to respond to anti-CD3 
(Fig. 4). In addition, the isotype control IgG1 antibody had 
no effect (Fig. 4), and polyclonal goat anti-IgM antibodies 
had the same effect as monoclonal anti-IgM (not shown). 
IP turnover, triggered by the activation of phospholipase 
C, is another measure of signal transduction by Ig. To confirm 
and extend the results obtained in calcium flux assays, we 
measured inositol turnover in response to anti-IgM antibody 
50 
Jurkat  IgM+B29  IgM+B29+MB1 
Figure 5.  Generation of inositol triphosphate by transfected  Jurkat cells. 
Cells metabolically labeled with [3H]myo-inositol were stimuhted with 
either anti-CD3, anti-human  IgM, or an IgG1 isotype control antibody, 
and inositol triphosphate was measured by extraction and anion exchange 
chromatography. The percent of unstimulated IP3 production is plotted 
on the y-axis, error bars indicate the SD from the mean (n -  2). Control, 
no primary antibody; other symbols are as in Fig. 4. 
(Fig. 5). Crosslinking Ig on the surface of T cell lines trans- 
fected with IgM and B29, or IgM, B29, and MB1, resulted 
in an increase in cellular IP3. In the same experiments, anti- 
IgM antibody had no effect on untransfected  Jurkat cells (Fig. 
5). Thus, the combination of Ig and B29 expressed on the 
surface of T  cells was fully competent to activate intracel- 
lular calcium mobilization, and phosphoinositol turnover. 
One biological effector function that is induced by activa- 
tion of the TCR is secretion of I1,2. To determine whether 
Ig activates this downstream response in transfccted T cells, 
we measured II.-2 production in response to anti-IgM (Fig. 
6). Jurkat cells that expressed either IgM and B29, or IgM, 
B29,  and MB1, secreted 11,2 in response to anti-IgM treat- 
ment. This response was specific, since untransfected Jurkat 
cells did not respond to anti-IgM but did produce II.-2 in 
Figure 6.  IL-2  secretion in response to anti-IgM by transfected Jurkat 
cells. Cell lines were stimulated with either anti-CD3, anti-human IgM, 
or an IgG1 isotype control antibody in the presence of PMA, or PMA 
alone. The mean and the SD (n -  3) of the number  of U/ml oflD2 secreted 
for two independent experiments is indicated. IgM+B29, Jurkat cells  trans- 
fected with IgM+B29 no. 5 (Fig. I B); other symbols are as in Hg. 4. 
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Figure 7.  IL-2  secretion in response to PC by transfected Jurkat cells. 
Cell lines were stimulated with either BSA, PC-BSA, or nothing. The 
mean and the SD (n  -  3) of the number of U/ml of II,2 secreted for 
two independent experiments is indicated. IgM+B29, Jurkat cells trans- 
feted with IgM+B29 no. 5 (Fig. 1 B); other symbols are as in Fig. 4. 
response to anti-CD3 stimulation. None of the lines were 
induced with the isotype control mAb (Fig.  6). 
Signal Transduction Induced by Antigen.  T lymphocytes re- 
spond to processed peptides associated with MHC on the 
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Figure 8.  Dose-response to PC-BSA, and blocking by monomeric PC 
in transfected Jurkat cells. (A) Calls loaded with Fura-2 were assayed 
fluorimetrically for calcium mobilization in response to increasing doses 
of PC-BSA. Calcium concentration 0,-axis) was calculated as indicated 
in Materials and Methods and plotted against PC-BSA concentration on 
a logarithmic scale (x-axis). The constructs transfected  and cell line  numbers 
are indicated. Diamonds represent IgM +B29+MB1-tnmfected  Jurkat cells, 
and squares  indicate IgM  + B29--tranff'ected  Jurkat cells. (B) IgM + B29-trans- 
feted cell line no. 5 was stimulated with 2.5 mM PC followed by 500 
ng/ml PC-BSA, and finally 5/tg/ml of anti-CD3 mAb as indicated by 
mows. PC, monomeric  phosphorylcholine; other symbols are as in Fig. 4. 
surface of other cells, whereas B cells respond to native an- 
tigens. To determine whether Jurkat cells expressing anti- 
PC-specific IgM would respond to antigens in the absence 
of MHC, they were challenged with PC-BSA (Figs. 4 and 
7). PC-BSA induced calcium flux and Ib2 secretion in T cell 
lines that expressed B29 in addition to IgM. Controls treated 
with albumin alone were always negative. Once again, in an- 
tigen stimulation experiments, T cells that expressed surface 
IgM alone failed to respond to receptor crosslinking (Fig. 4). 
The potential additive or synergistic effects of MB1 were 
assessed in dose-response experiments (Fig. 8 A). We found 
that cell lines expressing equivalent amounts of surface IgM 
had similar responses to increasing concentrations of PC-BSA 
whether or not MB1 was present. In both cases, a response 
was obtained with as little as 0.5 ng/ml of PC-BSA, and the 
response reached a peak at 0.1-0.5 mg/ml of PC-BSA. The 
responses decreased at doses >1 mg/ml, consistent with the 
possibility that signaling was dependent on receptor cross- 
linking. The role of receptor crosslinking in signaling was 
further examined by treating cells with monomeric PC (Fig. 
8 B). Monomeric antigen did not induce signaling. How- 
ever, pretreatment of the cells with monomeric PC blocked 
the response to PC-BSA (Fig.  8 B). Thus, crosslinking of 
the transfected Ig appears to be an important feature of the 
signaling mechanism. 
Discussion 
The finding that Ig is associated with several other pro- 
teins on the plasma membrane of B cells raises a number of 
interesting questions about the role of these accessory mole- 
cules in receptor assembly and signal transduction. In this 
study, we demonstrate that coexpression of IgM and B29 
is sufficient  to reconstitute both Ig surface expression and 
function in T  cells. 
There is persuasive evidence that two of the Ig-associated 
proteins, MB1 and B29, are important for transport of Ig 
to the surface of B cells and fibroblasts. B cell lines that lack 
MB1 fail to express surface IgM, and this phenotype can be 
restored by transfection of cloned MB1 (10). Thus, MB1 is 
required for receptor assembly in B cells. Similarly, in fibro- 
blasts, both MB1 and B29 are required for surface expression 
of IgM, however, other Ig isotypes can be expressed on the 
surface of fibroblasts with B29 even in the absence of MB1 
(12). One attractive model of IgM receptor structure pro- 
poses that IgM interacts with a pair of MB1 and B29 hetero- 
dimers. In this model, MB1 and B29 are disulfide linked and 
interact with IgM in part through polar amino acid side chains 
in the transmembrane domains. In view of this proposed 
quaternary structure, it was surprising to find that MB1 was 
not strictly required for either surface expression,  or func- 
tion of IgM antigen receptors on transfected T cells. Failure 
to obtain a functional antigen receptor with MB1 alone was 
not simply due to lack of transfected gene expression (Fig. 
2 B) or to an inactive MB1 protein, since MB1 was associated 
with IgM and B29 in T cells transfected with all three com- 
ponents (Fig. 3). Furthermore, addition of MB1 to cell lines 
that also expressed B29 and IgM, but had low levels of sur- 
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One interpretation of our results is that one or more T cell 
components, not present in fibroblasts or B cells, can substi- 
tute for MB1. 
Progress in understanding the mechanism of signaling by 
the Ig receptor has been hindered by the multisubunit nature 
of the receptor. In addition, transfected Ig expressed on the 
surface of fibroblasts does not appear to be functional in signal 
transduction, even in the presence of B29 and MB1 (12). The 
ability to produce a functional receptor by transfection in T 
cells establishes  that there must be structural similarity be- 
tween the T  and B cell signal transduction pathways. This 
observation should greatly simplify the structural and func- 
tional analysis  of IgM antigen receptor. 
An intriguing question raised by our results is how the 
IgM receptor can interact with the T cell signal transduction 
apparatus. Although there are many similarities between the 
signaling pathways of B and T cells, there are several significant 
differences. For example, much experimental evidence points 
to activation of tyrosine kinases as one of the first steps in 
the signal transduction pathways of the TCK (reviewed in 
reference 33) and IgM (34, 35). Indeed, both B29 and MB1 
are rapidly phosphorylated upon IgM crosslinking in B cells 
(9, 35, 36), and both ~'and ZAP-70 are phosphorylated upon 
TCR crosslinking in T  cells (37,  38). However the specific 
kinases coimmunoprecipitated with IgM in B cells (p561yn, 
fyn,  and blk) (39, 40)  differ from that associated  with the 
TCK (fyn) (41). There are at least two mechanisms by which 
IgM and B29 could overcome the apparent differences be- 
tween the signal transduction apparatus of T and B cells. First, 
IgM and B29 could interact directly with and activate one 
of the many T cell protein tyrosine kinases by forming a com- 
plex with structural similarity to CD3 ~" or e. Crosslinking 
of the isolated ~" or e chains is sufficient to induce signaling 
in transfected T cells (14, 15, 17), and there is sequence ho- 
mology between ~', e, and B29 (11). Indeed, mutations in 
the shared intracytoplasmic consensus sequence destroy signal 
transduction mediated by e. A second mechanism to explain 
signal transduction by IgM and B29 in T cells would involve 
direct association of IgM with T cell-encoded proteins that 
in turn make the appropriate cellular connections. The CD3 
components are particularly appealing candidates for this func- 
tion since they are both structurally and functionally related 
to B29 and MB1 (11). However, we have been unable to iden- 
tify proteins other than a polypeptide with the apparent mo- 
lecular weight of B29  associated  with IgM in Jurkat cells 
transfected with IgM and B29. Additional polypeptides were 
detected in the IgM, B29, and MB1 transfectants, but, we 
noted no apparent effect on calcium flux, inositol metabo- 
lism, or II~2 secretion (Figs. 4-8). Although the significance 
of these additional receptor-associated proteins remains un- 
clear, we continue to pursue the possibility of a hybrid receptor 
complex.  Experiments with  mutant  T  cell lines  that  are 
deficient in specific TCR components should clarify this issue, 
and potentially elucidate the structural and functional rela- 
tionship between the Ig- and TCK-associated proteins.  In 
addition, our experiments suggest that it may be possible 
to use B cell lines to functionally reconstitute the TCR from 
cloned components. 
One major difference between the TCR and Ig antigen 
receptors is the nature of the antigen recognized by the two 
receptors. Igs recognize antigens directly, whereas recogni- 
tion of antigen by the TCK is restricted by MHC. The re- 
quirement for MHC recognition places severe limitations on 
the targets recognized by T cells, and makes transfer of cel- 
lular immunity MHC restricted. For this reason, there has 
been considerable interest in modifying T  cell recognition 
to abrogate the MHC requirement. Several groups have shown 
that chimeric receptors composed of Ig variable regions and 
TCK constant regions can function in an MHC-independent 
fashion. However, this approach is limited by the formation 
of heterodimeric receptors composed of the endogenous TCR 
and the transfected V-Ig C-TCR chimeras, as well as forma- 
tion of Vh-C3 homodimers (42-45). Another approach has 
been to produce CD4 ~" chimeric proteins that were capable 
of directing T cells to targets that express HIV envelope pro- 
teins (15). In this system, antigen binding results in T  cell 
activation via CD4  ~" crosslinking. Our reconstitution ex- 
periments offer an additional, more general solution to the 
difficult problem of MHC restriction in transfer of cellular 
immunity. T cells that express functional Ig antigen receptors 
would have the potential for recognizing any antigen recog- 
nized by antibodies in an MHC-independent fashion. 
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